
ZW4864 free base
CAS No. 2632259-92-6
ZW4864 free base( —— )
Catalog No. M37644 CAS No. 2632259-92-6
ZW4864 (free base) is an orally active and selective β-catenin/B-Cell lymphoma 9 protein-protein interaction (β-catenin/BCL9 PPI) inhibitor, with a K_i value of 0.76 μM and an IC_50 value of 0.87 μM .
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 248 | Get Quote |
![]() ![]() |
5MG | 392 | Get Quote |
![]() ![]() |
10MG | 587 | Get Quote |
![]() ![]() |
25MG | 906 | Get Quote |
![]() ![]() |
50MG | 1224 | Get Quote |
![]() ![]() |
100MG | 1611 | Get Quote |
![]() ![]() |
500MG | 3231 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameZW4864 free base
-
NoteResearch use only, not for human use.
-
Brief DescriptionZW4864 (free base) is an orally active and selective β-catenin/B-Cell lymphoma 9 protein-protein interaction (β-catenin/BCL9 PPI) inhibitor, with a K_i value of 0.76 μM and an IC_50 value of 0.87 μM .
-
DescriptionZW4864 (free base) is an orally active and selective β catenin/B-Cell lymphoma 9 protein?protein interaction (β catenin/BCL9 PPI) inhibitor. ZW4864 (free base) inhibits β catenin/BCL9 PPI with a Ki value of 0.76 μM and an IC50 value of 0.87 μM.
-
In VitroWestern Blot Analysis Cell Line:SW480 and MBA-MD-231 cells Concentration:10~40 μM Incubation Time:24 hours Result:Decreased the expression levels of Axin2 and cyclin D1 proteins.Apoptosis Analysis Cell Line:MDA-MB231, MCF10A and MDA-MB-468 cells Concentration:10~40 μM Incubation Time:72 hours Result:Selectively triggered rapid apoptosis of triple-negative breast cancer cells with hyperactive β-catenin signaling while sparing normal mammary epithelial MCF10A cells.RT-PCR Cell Line:SW480 and MBA-MD-231 cells Concentration:10~40 μ Incubation Time:24 hours Result:Suppressed the transcription of β-catenin target genes in a concentration-dependent manner without affecting the expression of HPRT, a house-keeper gene, in both SW480 and Wnt 3a-activated MDA-MB-231 cells.
-
In VivoAnimal Model:C57BL/6 mice Dosage:20 mg/kg (Pharmacokinetic Analysis)Administration:P.o.Result:Exhibited good pharmacokinetic properties with an oral bioavailability (F) of 83%.Animal Model:Mice Dosage:90 mg/kg Administration:P.o.Result:Showed a variation in tumor growth in mice.
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorWnt/beta-catenin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2632259-92-6
-
Formula Weight570.72
-
Molecular FormulaC33H42N6O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (175.22 mM; Ultrasonic )
-
SMILESCC(C)(Oc1cccc(c1)N1CCC[C@H](C1)C(=O)N(Cc1ccc(cc1)-c1cn[nH]c1)C1CC1)C(=O)N1CCNCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang Z, et al. Discovery of an Orally Bioavailable Small-Molecule Inhibitor for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction. J Med Chem. 2021;64(16):12109-12131.?
molnova catalog



related products
-
Vantictumab
Vantictumab (OMP-18R5) is a humanized anti-FZD1/2/5/7/8 monoclonal antibody that inhibits Wnt pathway signaling and is used in research studies for the treatment of metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.
-
ABC99
ABC99 is a selective irreversible inhibitor of the wnt-deacylating enzyme. ABC99 inhibited NOTUM (IC50: 13 nM). It also showed excellent selectivity across the serine hydrolase family.
-
β-catenin-IN-2
β-catenin-IN-2 is a potent inhibitor of β-catenin that can be used in colorectal cancer research.